TABLE 2. Statistical Analysis of 51 COVID-19 Patients (Severe COVID-19 and Non-Severe COVID-19).
| Index | Severe (n = 21) | Non-severe (n = 30). | p-value |
|---|---|---|---|
| Age (years) | 61.43±17.64 | 42.30±11.53 | 0.00 |
| WBC (10^9/L) | 5.06±2.23 | 4.79±1.89 | 0.64 |
| NEU (%) | 69.50±14.10 | 55.33±9.98 | 0.00 |
| LY (%) | 21.20±10.54 | 33.25±7.90 | 0.00 |
| MONO (%) | 8.71±4.04 | 10.35±3.19 | 0.11 |
| EOS (%) | 0.44±1.22 | 0.88±0.96 | 0.16 |
| BA (%) | 0.15±0.19 | 0.19±0.13 | 0.38 |
| NEU (10^9/L) | 3.68±2.22 | 2.74±1.59 | 0.08 |
| LY (10^9/L) | 0.95±0.46 | 1.50±0.45 | 0.00 |
| MONO (10^9/L) | 0.40±0.19 | 0.48±0.18 | 0.15 |
| EOS (10^9/L) | 0.01±0.03 | 0.04±0.04 | 0.02 |
| BA (10^9/L) | 0.01±0.01 | 0.01±0.01 | 0.22 |
| RBC (10^12/L) | 4.44±0.66 | 4.58±0.47 | 0.35 |
| HB (g/L) | 132.67±18.68 | 138.53±14.71 | 0.22 |
| HCT (%) | 40.25±4.92 | 41.83±3.87 | 0.21 |
| MCH (pg) | 29.652±1.22 | 30.28±1.47 | 0.11 |
| MCV (fL) | 90.35±3.97 | 91.54±4.08 | 0.30 |
| MCHC (g/L) | 323.76±21.23 | 330.87±10.77 | 0.12 |
| RDW (%) | 12.48±0.55 | 12.083±0.58 | 0.02 |
| RDW-SD (fL) | 41.27±1.74 | 40.19±2.47 | 0.09 |
| MPV (fL) | 10.42±0.92 | 10.43±0.95 | 0.97 |
| PLT (10^9/L) | 170.14±63.10 | 205.30±69.82 | 0.07 |
| PCT (%) | 0.19±0.07 | 0.21±0.07 | 0.26 |
| PDW (%) | 12.62±2.29 | 12.77±2.01 | 0.81 |
| P-LCR (%) | 28.14±7.35 | 28.10±7.09 | 0.98 |
| N/L | 5.35±5.97 | 1.85±0.86 | 0.02 |
| P/L | 12.53±13.63 | 6.52±2.62 | 0.02 |